Angelini Ventures focuses its investments on cutting-edge startups in biotechnology and digital health, aiming to transform healthcare, improve patient outcomes, and address unmet needs, particularly in vulnerable populations. Their strategy involves investing globally in disruptive innovation across segments like Biotech, TechBio, Connected Health Devices, Digital Diagnostics & Therapeutics, and Hybrid Care Platforms, typically from Seed to Series A rounds.
Portfolio
5
Fund Size
$300M
Top Stage
Series C
Last 12 Mo
2
Stage Distribution
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Laigo Bio | Seed | $11.5M | Dec 2025 |
| CoMind | Series C | $60M | Oct 2025 |
| Avation Medical | Series C | $22M | Feb 2024 |
| Noctrix Health, Inc. | Series C | $40M | Jan 2024 |
| Cadence Neuroscience | Series B | $26M | May 2023 |
Top Co-Investors
OrbiMed1 shared
Kurma Partners1 shared
Eurazeo1 shared
Plural1 shared
LocalGlobe1 shared
Octopus Ventures1 shared
Crane1 shared
Entrepreneur First1 shared
ShangBay Capital1 shared
Asahi Kasei1 shared
JobsOhio1 shared
Avestria1 shared
F-Prime Capital1 shared
Mayo Clinic1 shared
Jazz Venture Partners1 shared
Last updated: 3 March 2026